Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Massachusetts General Hospital
With
The hepatitis C virus is actively secreted by the liver of infected patients while bound to very low density lipoprotein (vLDL). The grapefruit flavonoid naringenin could be used to block vLDL secretion and lower the circulating viral titer. Hypothesis: Treatment with naringenin will block vLDL and HCV secretion in persons infected with HCV. Primary Objective To study the safety and pharmacokinetics of a single-dose of naringenin Secondary Objectives 1. To study the changes in circulating HCV titers during the transition from a fasted to fed state. 2. To study the changes in circulating HCV titers after administration of the grapefruit flavonoid naringenin. 3. To study effects of naringenin on vLDL secretion. This is a single-arm, cross over study where placebo is administered during a transition from a fasted to a fed state, then the protocol is repeated with a single dose of naringenin plus cyclodextrin, using the previous measurements as his/her own control
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
